ORPHA:99966
Atypical teratoid rhabdoid tumor
Also known as: ATRT
Publications
1,556,287
Trials
38
Interventional, condition-specific
Researchers
1,249
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare, highly malignant central nervous system (CNS) rhabdoid tumor (RT) found almost exclusively in children.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0020560
- UMLS:C1266184
- NCIT:C6906
Additional Mondo synonyms (42)
AT/RT · ATT/RHT · CNS rhabdoid neoplasm · CNS rhabdoid tumor · CNS rhabdoid tumour · atypical teratoid/rhabdoid tumor · atypical teratoid/rhabdoid tumor (WHO grade IV) · atypical teratoid/rhabdoid tumor (morphologic abnormality) · atypical teratoid/rhabdoid tumour (WHO grade IV) · atypical teratoid/rhabdoid tumour (morphologic abnormality) · central nervous system rhabdoid neoplasm · central nervous system rhabdoid tumor · central nervous system rhabdoid tumour · malignant brain rhabdoid neoplasm · malignant brain rhabdoid tumor · malignant brain rhabdoid tumour · malignant rhabdoid neoplasm of brain · malignant rhabdoid neoplasm of the brain · malignant rhabdoid tumor of brain · malignant rhabdoid tumor of the brain · malignant rhabdoid tumour of brain · malignant rhabdoid tumour of the brain · primary malignant brain rhabdoid neoplasm · primary malignant brain rhabdoid tumor · primary malignant brain rhabdoid tumour · primary malignant rhabdoid neoplasm of brain · primary malignant rhabdoid neoplasm of the brain · primary malignant rhabdoid tumor of brain · primary malignant rhabdoid tumor of the brain · primary malignant rhabdoid tumour of brain · primary malignant rhabdoid tumour of the brain · rhabdoid neoplasm of CNS · rhabdoid neoplasm of central nervous system · rhabdoid neoplasm of the CNS · rhabdoid neoplasm of the central nervous system · rhabdoid tumor of CNS · rhabdoid tumor of central nervous system · rhabdoid tumor of the CNS · rhabdoid tumor of the central nervous system · rhabdoid tumour of CNS · rhabdoid tumour of central nervous system · rhabdoid tumour of the central nervous system
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,556,287 matched papers (930,491 in last 10 years) Source
- Phenotype characterisedPresent
18 HPO annotations (e.g. Atypical teratoid/rhabdoid tumor; Rhabdoid tumor of the kidney; Hydrocephalus) Source
- Animal modelPresent
3 genotype models (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
38 matched on ClinicalTrials.gov (10 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
18
Associated phenotypes · MONDO:0020560
- Atypical teratoid/rhabdoid tumor
- Rhabdoid tumor of the kidney
- Hydrocephalus
- Apathy
- Ataxia
Showing 5 of 18 — open Monarch for the full list.
Animal models (Monarch / Alliance)
3
Model associations linked to this Mondo ID
- Smarcb1tm1Sho/Smarcb1+ [background:] involves: 129S6/SvEvTac * C57BL/6J * DBA/2J·MGI:5538531·Mus musculus
- Smarcb1tm1Gvk/Smarcb1tm1Gvk [background:] involves: 129/Sv * C57BL/6J * SJL/J·MGI:3603677·Mus musculus
- Smarcb1tm1Sho/Smarcb1+ Tg(LPV-TAg121)2Tvd/0 [background:] involves: 129S6/SvEvTac * C57BL/6J * DBA/2J·MGI:5538529·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
37
Drugs / clinical candidates · MONDO_0020560
- CARBOPLATIN·phase 3
- CISPLATIN·phase 3
- CYCLOPHOSPHAMIDE·phase 3
- ETOPOSIDE·phase 3
- FILGRASTIM·phase 3
- METHOTREXATE·phase 3
- TEMOZOLOMIDE·phase 3
- THIOTEPA·phase 3
- VINCRISTINE·phase 3
- ALISERTIB·phase 2
- ANTINEOPLASTON A10·phase 2
- BEVACIZUMAB·phase 2
- BORTEZOMIB·phase 2
- CELECOXIB·phase 2
- CYTARABINE·phase 2
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,556,287
1,556,287 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,556,287 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
930,491 in the last 10 years · low confidence
Phrase hits: 1,556,287 · MeSH hits: 0
Who's working on it?
1,249
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Huang A5 papers · 2026
Division of Haematology/Oncology, Hospital for Sick Children, Department of Pediatrics, Arthur and Sonia Labatt Brain Tumor Research Centre, University of Toronto, Toronto, Canada (D.P., A.B., F.Y., M.L., A.H.).
Papers in Europe PMC - 02Frühwald MC4 papers · 2026
Pediatrics and Adolescent Medicine, University Hospital Augsburg, Swabian Children's Cancer Center, Augsburg, Germany.
Papers in Europe PMC - 03Hasselblatt M4 papers · 2026
Institute of Neuropathology, University Hospital Münster, Münster, Germany.
Papers in Europe PMC - 04Sahm F4 papers · 2025
Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Papers in Europe PMC - 05Crotty EE3 papers · 2026
The Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle (S.M.M., E.J.G., E.E.C., K.B., M.C.B., H.C., J.M.O.).
Papers in Europe PMC - 06Das S3 papers · 2026
University of Alberta and Stollery Children's Hospital, Edmonton, AB, Canada.
Papers in Europe PMC - 07Deng Y3 papers · 2026
Division of Pediatric Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Bloomberg Children's Center, Baltimore, MD, USA 21205.
Papers in Europe PMC - 08El-Beltagy M3 papers · 2025
Department of Neurosurgery, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.
Papers in Europe PMC - 09Fouladi M3 papers · 2026
Pediatric Neuro-Oncology Program, Nationwide Children's Hospital, Columbus (M.F.).
Papers in Europe PMC - 10Gajjar A3 papers · 2026
Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
38
interventional trials for this specific condition
38 interventional trials matched this specific condition name; 10 currently recruiting in our sample. 39 trials are registered for rhabdoid tumor, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
38 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 96.6th percentile).
low confidence · 96.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
38 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07087002·RECRUITING·GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Not reviewed·Conditions: Medulloblastoma · Central Nervous System Embryonal Tumor · Refractory Medulloblastoma · Recurrent Medulloblastoma·Matched via name phrase
- NCT07513194·NOT YET RECRUITING·GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
Not reviewed·Conditions: Atypical Teratoid Rhabdoid Tumor · Central Nervous System Rhabdoid Tumor·Matched via name phrase
- NCT06193759·RECRUITING·Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Not reviewed·Conditions: Medulloblastoma, Childhood · Atypical Teratoid/Rhabdoid Tumor of CNS · Embryonal Tumor With Multilayered Rosettes · Pineoblastoma·Matched via name phrase
- NCT07447076·RECRUITING·Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Not reviewed·Conditions: Recurrent Atypical Teratoid/Rhabdoid Tumor · Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS·Matched via name phrase
- NCT07664176·NOT YET RECRUITING·NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Not reviewed·Conditions: Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma · High Grade Gliomas · Medulloblastoma Recurrent · Ependymoma Recurrent·Matched via name phrase
- NCT07331064·NOT YET RECRUITING·Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor
Not reviewed·Conditions: High Grade Gliomas · Atypical Teratoid Rhabdoid Tumors (ATRT) · Diffuse Midline Glioma · DIPG·Matched via name phrase
- NCT06942039·RECRUITING·Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Not reviewed·Conditions: CNS Embryonal Tumor · CNS, Medulloblastoma · Atypical Teratoid Rhabdoid Tumor · Medulloblastoma, Childhood·Matched via name phrase
- NCT07390539·NOT YET RECRUITING·B7-H3.CD28Z.CART in CNS Neoplasms
Not reviewed·Conditions: Central Nervous System Neoplasms · Brain Tumor · Brain Tumor, Recurrent · Brain Tumor, Pediatric·Matched via name phrase
- NCT04185038·RECRUITING·Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Not reviewed·Conditions: Central Nervous System Tumor · Diffuse Intrinsic Pontine Glioma · Diffuse Midline Glioma · Ependymoma·Matched via name phrase
- NCT06465199·RECRUITING·Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Not reviewed·Conditions: Atypical Teratoid/Rhabdoid Tumor · Embryonal Tumor With Multilayered Rosettes · Ewing Sarcoma · Diffuse Intrinsic Pontine Glioma·Matched via name phrase
Broader category: rhabdoid tumor
39
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06625190·RECRUITING·Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Not reviewed·Conditions: Neuroblastoma · Rhabdomyosarcoma · Synovial Sarcoma · Peripheral Nerve Sheath Tumors·Matched via name phrase
- NCT04541082·RECRUITING·Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Not reviewed·Conditions: Central Nervous System Neoplasms · Glioblastoma · Gliosarcoma, Adult · Anaplastic Oligodendroglioma·Matched via name phrase
- NCT04901702·RECRUITING·Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Not reviewed·Conditions: Recurrent Solid Tumor · Recurrent Ewing Sarcoma · Recurrent Hepatoblastoma · Recurrent Malignant Germ Cell Tumor·Matched via name phrase
- NCT06198296·RECRUITING·Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Not reviewed·Conditions: Hepatoblastoma · Hepatocellular Carcinoma · Wilms Tumor · Malignant Rhabdoid Tumor·Matched via name phrase
- NCT05985161·RECRUITING·A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Not reviewed·Conditions: Wilms Tumor · Rhabdoid Tumor · Malignant Peripheral Nerve Sheath Tumors · MPNST·Matched via name phrase
- NCT04897321·RECRUITING·B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Not reviewed·Conditions: Pediatric Solid Tumor · Osteosarcoma · Rhabdomyosarcoma · Neuroblastoma·Matched via name phrase
- NCT04715191·RECRUITING·Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Not reviewed·Conditions: Liver Cancer · Rhabdomyosarcoma · Malignant Rhabdoid Tumor · Liposarcoma·Matched via name phrase
- NCT07148050·RECRUITING·Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Not reviewed·Conditions: Solid Tumor (Excluding CNS) · Liver Cell Carcinoma · Malignant Rhabdoid Tumor · Yolk Sac Tumor·Matched via name phrase
- NCT06622941·RECRUITING·Study to ONO-4538 in Patients With Rhabdoid Tumor
Not reviewed·Conditions: Rhabdoid Tumor·Matched via name phrase
Observational and natural-history studies
4 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07589361·NOT YET RECRUITING·Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors
Not reviewed·Conditions: Pediatric Central Nervous System Tumors · Medulloblastoma · Germinoma · Ependymoma·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 2 · after dedupe 2 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 2 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (2)
- ctis·2024-515626-92-00·Authorised, ongoing·MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial - A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma, ependymoma, ATRT and rare CNS tumors
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN60158641·No longer recruiting·Embryo development of fresh versus vitrified metaphase II after intracytoplasmic sperm injection (ICSI): a sibling-oocyte study
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Atypical teratoid rhabdoid tumor — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Atypical teratoid rhabdoid tumor" OR "AT/RT" OR "ATT/RHT" OR "CNS rhabdoid neoplasm" OR "CNS rhabdoid tumor" OR "CNS rhabdoid tumour" OR "atypical teratoid/rhabdoid tumor" OR "atypical teratoid/rhabdoid tumor (WHO grade IV)" OR "atypical teratoid/rhabdoid tumor (morphologic abnormality)" OR "atypical teratoid/rhabdoid tumour (WHO grade IV)" OR "atypical teratoid/rhabdoid tumour (morphologic abnormality)" OR "central nervous system rhabdoid neoplasm" OR "central nervous system rhabdoid tumor" OR "central nervous system rhabdoid tumour" OR "malignant brain rhabdoid neoplasm" OR "malignant brain rhabdoid tumor" OR "malignant brain rhabdoid tumour" OR "malignant rhabdoid neoplasm of brain" OR "malignant rhabdoid neoplasm of the brain" OR "malignant rhabdoid tumor of brain" OR "malignant rhabdoid tumor of the brain" OR "malignant rhabdoid tumour of brain" OR "malignant rhabdoid tumour of the brain" OR "primary malignant brain rhabdoid neoplasm" OR "primary malignant brain rhabdoid tumor" OR "primary malignant brain rhabdoid tumour" OR "primary malignant rhabdoid neoplasm of brain" OR "primary malignant rhabdoid neoplasm of the brain" OR "primary malignant rhabdoid tumor of brain" OR "primary malignant rhabdoid tumor of the brain" OR "primary malignant rhabdoid tumour of brain" OR "primary malignant rhabdoid tumour of the brain" OR "rhabdoid neoplasm of CNS" OR "rhabdoid neoplasm of the CNS" OR "rhabdoid neoplasm of central nervous system" OR "rhabdoid neoplasm of the central nervous system" OR "rhabdoid tumor of CNS" OR "rhabdoid tumor of the CNS" OR "rhabdoid tumor of central nervous system" OR "rhabdoid tumor of the central nervous system"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Atypical teratoid rhabdoid tumor" OR "AT/RT" OR "ATT/RHT" OR "CNS rhabdoid neoplasm" OR "CNS rhabdoid tumor" OR "CNS rhabdoid tumour" OR "atypical teratoid/rhabdoid tumor" OR "atypical teratoid/rhabdoid tumor (WHO grade IV)" OR "atypical teratoid/rhabdoid tumor (morphologic abnormality)" OR "atypical teratoid/rhabdoid tumour (WHO grade IV)" OR "atypical teratoid/rhabdoid tumour (morphologic abnormality)" OR "central nervous system rhabdoid neoplasm" OR "central nervous system rhabdoid tumor" OR "central nervous system rhabdoid tumour" OR "malignant brain rhabdoid neoplasm" OR "malignant brain rhabdoid tumor" OR "malignant brain rhabdoid tumour" OR "malignant rhabdoid neoplasm of brain" OR "malignant rhabdoid neoplasm of the brain" OR "malignant rhabdoid tumor of brain" OR "malignant rhabdoid tumor of the brain" OR "malignant rhabdoid tumour of brain" OR "malignant rhabdoid tumour of the brain" OR "primary malignant brain rhabdoid neoplasm" OR "primary malignant brain rhabdoid tumor" OR "primary malignant brain rhabdoid tumour" OR "primary malignant rhabdoid neoplasm of brain" OR "primary malignant rhabdoid neoplasm of the brain" OR "primary malignant rhabdoid tumor of brain" OR "primary malignant rhabdoid tumor of the brain" OR "primary malignant rhabdoid tumour of brain" OR "primary malignant rhabdoid tumour of the brain" OR "rhabdoid neoplasm of CNS" OR "rhabdoid neoplasm of the CNS" OR "rhabdoid neoplasm of central nervous system" OR "rhabdoid neoplasm of the central nervous system" OR "rhabdoid tumor of CNS" OR "rhabdoid tumor of the CNS" OR "rhabdoid tumor of central nervous system" OR "rhabdoid tumor of the central nervous system"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 38 interventional · 4 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"rhabdoid tumor"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: ATRT; rhabdoid tumour of CNS; rhabdoid tumour of the CNS; rhabdoid tumour of central nervous system; rhabdoid tumour of the central nervous system
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (1556287) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T06:47:57.157Z
